Oftung F, Geluk A, Lundin K E, Meloen R H, Thole J E, Mustafa A S, Ottenhoff T H
Department of Vaccines, National Institute of Public Health, Oslo, Norway.
Infect Immun. 1994 Dec;62(12):5411-8. doi: 10.1128/iai.62.12.5411-5418.1994.
By combining a DNA subclone and synthetic-peptide approach, we mapped epitopes of the immunogenic mycobacterial 70-kDa heat shock protein (HSP70) recognized by human CD4+ T-cell clones and lines. In addition, we identified the respective HLA-DR molecules used in antigen presentation. The donor groups used were healthy persons immunized with killed Mycobacterium leprae and tuberculoid leprosy patients. The results show that the N-terminal part of the HSP70 molecule contains three different T-cell epitopes, of which two were presented by DR7 (amino acids [aa] 66 to 82 and 210 to 226) and one was presented by DR3 (aa 262 to 274). The C-terminal part contains one epitope (aa 413 to 424) presented by HLA-DR2. The C-terminal epitope shows extensive homology to the corresponding region of the human HSP70 sequence. All of the T-cell epitopes identified were presented by only one particular HLA-DR molecule. We also found that HLA-DR5 and DRw53 can present HSP70 to T cells, demonstrating the presence of additional epitopes not yet defined at the peptide level. On the basis of the donors used in this study, recognition of HSP70 at the epitope level seems to be ruled by the restriction elements expressed by the donor rather than by any difference in reactivity between healthy individuals and patients. In conclusion, mycobacterial HSP70 is relevant to subunit vaccine design since it contains a variety of T-cell epitopes presented in the context of multiple HLA-DR molecules.
通过结合DNA亚克隆和合成肽方法,我们绘制了人类CD4 + T细胞克隆和细胞系识别的免疫原性分枝杆菌70 kDa热休克蛋白(HSP70)的表位图谱。此外,我们确定了抗原呈递中使用的各自的HLA - DR分子。所使用的供体组为用灭活麻风杆菌免疫的健康人和结核样型麻风病患者。结果表明,HSP70分子的N端部分包含三个不同的T细胞表位,其中两个由DR7呈递(氨基酸[aa] 66至82和210至226),一个由DR3呈递(aa 262至274)。C端部分包含一个由HLA - DR2呈递的表位(aa 413至424)。C端表位与人HSP70序列的相应区域显示出广泛的同源性。所有鉴定出的T细胞表位仅由一种特定的HLA - DR分子呈递。我们还发现HLA - DR5和DRw53可以将HSP70呈递给T细胞,这表明在肽水平上还存在尚未确定的其他表位。基于本研究中使用的供体,在表位水平对HSP70的识别似乎由供体表达的限制元件决定,而不是由健康个体和患者之间的反应性差异决定。总之,分枝杆菌HSP70与亚单位疫苗设计相关,因为它包含多种在多个HLA - DR分子背景下呈递的T细胞表位。